Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging.
about
TP53 mutations and survival in squamous-cell carcinoma of the head and neck.Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma.Volumetric PET/CT parameters predict local response of head and neck squamous cell carcinoma to chemoradiotherapyCyclin D1 overexpression is associated with poor clinicopathological outcome and survival in oral squamous cell carcinoma in Asian populations: insights from a meta-analysisPlasma vascular endothelial growth factor dysregulation in defining aggressiveness of head and neck squamous cell carcinomaPrognostic Factors and Treatment Outcomes of Parotid Gland Cancer: A 10-Year Single-Center Experience.Evaluation of histomorphological and immunohistochemical parameters as biomarkers of cervical lymph node metastasis in squamous cell carcinoma of oral cavity: A retrospective study.Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma.Impact of FDG-PET on prediction of clinical outcome after concurrent chemoradiotherapy in hypopharyngeal carcinoma.Prognostic value of volumetric FDG PET/CT parameters in patients with oral tongue squamous cell carcinoma who were treated by superselective intra-arterial chemoradiotherapy.Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a meta-analysis.Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: a high risk area.Identification of epidermal growth factor receptor (EGFR) exon 20 single nucleotide polymorphism in Chinese squamous cell carcinoma of head and neck (SCCHN).A Predictive Model to Determine the Pattern of Nodal Metastasis in Oral Squamous Cell Carcinoma.
P2860
Q30366618-F8FACEF1-E5F6-4BA1-A6CA-ECA6550F6D57Q30430971-38C5DA4E-2924-4A33-8484-1A473EC8418FQ34998582-1D9F451E-144C-4AF2-8DAC-C1CCD7D8D9B9Q35133444-1B1F9C5F-54E2-495A-B88A-BD532E652362Q35636261-BEEBF035-7506-4E16-9B34-CF1276AFB19BQ38552560-81FBA369-A090-4B4E-A4D4-6743790C8EE3Q41528502-1C847542-B408-4EB2-BA62-FD1D85FC3080Q43937949-4E433DA7-1D42-415F-9E69-A812F428DDEDQ46022236-CB604368-C22C-4096-9BD3-E47F2A383BACQ48177211-FAA142FB-8478-4084-9396-D627AE1758BEQ51342568-D4FF314A-045B-469B-918E-CBC5C0A4B6EEQ53272391-F46BC2E6-AAFF-4415-A276-3657F0CD0F20Q54457108-07144558-8ACD-4AC5-9478-5ABB58CE8CBDQ54957614-7CBA1353-B1B7-4DE9-92BC-C226154502AD
P2860
Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Molecular markers predictive o ...... of a model beyond TNM staging.
@ast
Molecular markers predictive o ...... of a model beyond TNM staging.
@en
type
label
Molecular markers predictive o ...... of a model beyond TNM staging.
@ast
Molecular markers predictive o ...... of a model beyond TNM staging.
@en
prefLabel
Molecular markers predictive o ...... of a model beyond TNM staging.
@ast
Molecular markers predictive o ...... of a model beyond TNM staging.
@en
P1476
Molecular markers predictive o ...... of a model beyond TNM staging.
@en
P2093
Salesiotis AN
P304
P356
10.1097/00001622-200005000-00008
P577
2000-05-01T00:00:00Z